Description
Cell of origin in diffuse large B-cell lymphoma: the way to targeted therapy?
Article: Cell of origin in diffuse large B-cell lymphoma: the way to targeted therapy?
€3.03
Related products
-
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart -
Article: Highlights in digestive oncology
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart -
Article: Highlights in gynaecological cancers
€3.03 Add to cart
